UPDATE: Morgan Stanley Reiterates Overweight Rating, Raises PT on HCA Holdings on Revised Outlook

In a report published Thursday, Morgan Stanley analyst Andrew Schenker reiterated an Overweight rating on HCA Holdings HCA, and raised the price target from $65.00 to $67.00. In the report, Morgan Stanley noted, “HCA raised its EBITDA guidance to $7B to $7.15B reflecting TX Medicaid payments and an improved reform outlook. We updated our ‘14 EBITDA estimate to $7.15B, the high end of guidance, reflecting our expectations for a 2.8% reform benefit. We remain OW and raise our PT to $67.” HCA Holdings closed on Wednesday at $60.99.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsAndrew SchenkerMorgan Stanley
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!